Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 12,411 | 15,165 | 13,888 | 15,135 | 18,452 |
| Cost of Goods | 4,812 | 5,541 | 4,702 | 4,881 | 5,646 |
| Gross Profit | 7,599 | 9,624 | 9,186 | 10,254 | 12,806 |
| Operating Expenses | 12,475 | 12,135 | 11,392 | 18,758 | 11,031 |
| Operating Income | -4,064 | -1,970 | -1,504 | -7,623 | 2,421 |
| Interest Expense | 436 | 560 | 516 | 730 | 900 |
| Other Income | -1,108 | -8,054 | 3,985 | -11,090 | 2,297 |
| Pre-tax Income | -5,608 | -10,584 | 1,965 | -19,443 | 3,818 |
| Income Tax | 10 | 0 | N/A | 437 | -122 |
| Net Income Continuous | -5,618 | -10,584 | 1,965 | -19,880 | 3,940 |
| Net Income Discontinuous | 0 | N/A | N/A | 62 | 54 |
| Net Income | $-5,618 | $-10,584 | $1,965 | $-19,818 | $3,994 |
| EPS Basic Total Ops | -0.53 | -1.05 | 0.21 | -3.18 | 0.65 |
| EPS Basic Continuous Ops | -0.53 | -1.05 | 0.21 | -3.19 | 0.64 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.01 | 0.01 |
| EPS Diluted Total Ops | -0.53 | -1.05 | -0.08 | -1.96 | 0.21 |
| EPS Diluted Continuous Ops | -0.53 | -1.05 | -0.08 | -1.98 | 0.20 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.04 | 0.01 |
| EPS Diluted Before Non-Recurring Items | -0.53 | -1.05 | -0.08 | -0.26 | 0.20 |
| EBITDA(a) | $-2,916 | $-1,056 | $-672 | $-6,133 | $3,735 |